| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.5 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |